Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Researchers.
- Curriculum.
- Publications.
- Presentations.
Institutions.
Projects.
Publications.
Partners.
Sponsors.
Equipment.
Knowhow.
Fields of Research.

Hammer Sabrina |

Presentations at scientific and public conferences

Blatterer, J; Hammer, S; Bierbaumer, S; Husic, R; Schmid, J; Schreiner, E; Tichy, H; Wagner, K; Verheyen, S The zebra among horses - COPA syndrome as a potentially underdiagnosed autoimmune disorder
EUR J HUM GENET. 2024; 32: 1035-1035. [Poster]
Web of Science FullText

Blatterer, J; Hammer, S; Wagner, K; Tichy, H; Schreiner, E; Spiegl, B; Bierbaumer, S; Smogavec, M; Lehner, R; Madritsch, S; Stadlmann, V; Hofer, M; Gerykova Bujalkova, M; Riepl, N; Umlauf, E; Mühlegger, B; Burkhard, S; Maurer, E; Schneebauer, E; Gröbner, E; Witsch-Baumgartner, M; Rötzer, K; Uyanik, G; Nagy, D; Maurer, M; Bader, I; Mayr, J; Ebner, S; Bogner, B; Pleyers, A; Kranewitter, W; Malli, T; Webersinke, G; Zschocke, J; Laccone, F; Verheyen, S Austrian Exome meetings – a nationwide competence sharing initiative
15th International Symposium on Variants in the Genome; MAY 13-15, 2024; Povoa de Varzim, PORTUGAL. 2024. [Poster]

Moser, T; Eberhard, A; Moser, MJ; Glawitsch, L; Hammer, S; Vlachos, G; Lazzeri, I; Ziegler, L; Bauernhofer, E; Monsberger N; Geigl, JB; Bauernhofer, T; Heitzer, E Linking liquids: cfDNA in urine and plasma as informative allies in metastasized prostate cancer.
Annual Meeting 2024. 2024; -AACR; APR 5-10, 2024; San Diego, USA. [Poster]
FullText

Schreiner, E; Bierbaumer, S; Blatterer, J; Hammer, S; Kuehberger, S; Tichy, H; Wagner, K; Verheyen, S Phenotype expansion of SAMD9L-associated Ataxia-Pancytopenia Syndrome
EUR J HUM GENET. 2024; 32: 1039-1040. [Poster]
Web of Science FullText

Eberhard, A; Moser, T; Hammer, S; Glawitsch, L; Ziegler, L; Vlachos, G; Lang, K; Lazzeri, I; Bauernhofer, T; Balic, M; Loibner, M; Heitzer, E Development of analysis workflows for urinary cell-free DNA in malignant disease
Advances in Circulating Tumor Cells - ACTC 2023; SEP 20-23, 2023; Skiathos, Greece. 2023. [Poster]
FullText

Eberhard, A; Moser, T; Hammer, S; Lang, K; Faschauner, P; Vlachos, G; Belic, J; Lazzeri, I; Pichler, M; Speicher, M; Bauernhofer, T; Heitzer, E Paired analysis of blood plasma and urine reveals complementary information in prostate cancer
DocDay; FEB 9, 2023; Graz, AUSTRIA. 2023. [Oral Communication]

Moser, T; Eberhard, A; Hammer, S; Glawitsch, L; Vlachos, G; Lazzeri, I; Lang, K; Faschauner, P; Belic, J; Pichler, M; Geigl, JB; Bauernhofer, T; Speicher, MR; Heitzer, E Bridging urinary and plasma-based circulating tumor DNA analysis in prostate cancer.
Symposium of the Comprehensive Cancer Center. 2023; -CCC-Trio New Frontiers in Translational Oncology & Immuno-Oncology; APR 27-28, 2023; Vienna, AUSTRIA. [Poster]

Moser, T; Eberhard, A; Hammer, S; Glawitsch, L; Vlachos, G; Lazzeri, I; Lang, K; Faschauner, P; Belic, J; Pichler, M; Geigl, JB; Bauernhofer, T; Speicher, MR; Heitzer, E. It's a match – ctDNA in urine and plasma reveal complementary information in prostate cancer.
13th International Symposium on Minimal Residual Cancer. 2023; -ISMRC; MAY 2-4, 2023; Hamburg, GERMANY. [Poster]

Schreiner, E; Bierbaumer, S; Blatterer, J; Hammer, S; Speicher, M; Tichy, H; Wagner, K; Verheyen, S Zusatzbefunde in der WES-HPO-Auswertung 2019-2023 am Grazer Institut für Humangenetik.
22. Jahrestagung der Österreichischen Gesellschaft für Humangenetik ; Sep 29, 2023; Wien, Österreich. 2023. [Oral Communication]

Schreiner, E; Blatterer, J; Bierbaumer, S; Hammer, S; Schwerin-Nagel, A; Tichy, H; Wagner, K; Speicher, M; Verheyen, S NXN-related Robinow-syndrome – Expansion of the clinical and genetic spectrum.
34. Jahrestagung der Deutschen Gesellschaft für Humangenetik e.V. ; Mar 15-17, 2023; Kassel, Germany. 2023. [Poster]

Kühberger, S; Hammer, S ; Schuuring, E; Groen, HJM; Heitzer, E Genome-wide copy number calling from enriched sequencing data to identify clinically relevant somatic copy number alterations
DocDay; FEB 10, 2022; 2022. [Onlinepräsentation]

Moser, T; Hasenleithner, SO; Waldispuehl-Geigl, J; Zhou, Q; Weber, S; Graf, R; Geigl, JB; Heitzer, E; Speicher, MR It’s in our blood: Improving cancer treatment monitoring via liquid biomarkers.
Festival of Genomics & Biodata; JAN 25-28, 2022; London, ENGLAND. 2022. [Oral Communication]

Schreiner, E; Blatterer, J; Tichy, H; Bierbaumer, S; Hammer, S; Artl, M; Wagner, K; Speicher, M; Verheyen, S X-linked recessive intellectual developmental disorders in females – an overlooked cause? 3 case reports from Graz.
21. Jahrestagung der Österreichischen Gesellschaft für Humangenetik; Sept 29-30, 2022; Graz, Austria. 2022. [Oral Communication]

Georgios Vlachos, Sabrina Weber, Tina Moser, Kevin Lang, Paul Faschauner, Anna Eberhard, Jelena Belic, Isaac Lazzeri, Martin Pichler, Michael Speicher, Thomas Bauernhofer, Ellen Heitzer Paired analysis of blood plasma and urine reveals complementary information in prostate cancer
Advances in circulating tumor cells ; SEP 22-25, 2021; Kalamata, GREECE. 2021. [Poster]
FullText

Kühberger, S; Weber, S; Graf, R; Moser, T; Spiegl, B, Hasenleithner, SO; Speicher, MR; Schuuring, E; Groen, HJM; Heitzer, E. Genomewide copy number calling from enriched sequencing data to identify clinically relevant somatic copy number alterations
5th Advances in Circulating Tumor Cells: “Liquid Biopsy in its best” (ACTC 2021) ; SEP 22-25, 2021; Kalamata, GREECE. 2021. [Poster]

Perakis, SO; Weber, S; Zhou, Q; Graf, R; Hojas, S; Riedl, JM; Gerger, A; Dandachi, N; Balic, M; Hoefler, G, Schuuring, E; Groen, HJM; Geigl, JB; Heiter, E; Speicher, MR Harnessing circulating tumor DNA to inform clinical decisions
Festival of Genomics & Biodata 2021; JAN 26-29, 2021; London, ENGLAND. 2021. [Onlinepräsentation]

Weber, S; van der Leest, P; Donker, HC; Schlange, T; Timens, W; Tamminga, M; Hasenleithner, SO; Graf, R; Moser, T; Spiegl, B; Yaspo, ML, Terstappen, LWMM; Sidorenkov, G; Hiltermann, TJN; Speicher, MR; Schuuring, E; Groen, HJM;Heitzer, E. Dynamic changes of circulating tumor DNA predict clinical outcome in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors
5th Advances in Circulating Tumor Cells: “Liquid Biopsy in its best” (ACTC 2021) ; SEP 22-25, 2021; Kalamata, GREECE. 2021. [Poster]

Moser, T; Waldispuehl-Geigl, J; Belic, J; Perakis, S; Weber, S; Zhou, Q; Sill, H; Lax, S; Kashofer, K; Hoefler, G; Schoellnast, H; Bauernhofer, T; Heitzer, E; Geigl, JB; Speicher, MR Early circulating tumor DNA dynamics as a real-time predictor of FOLFOX efficacy in advanced colorectal cancer patients
CANCER RES. 2020; 80(16): Doi: 10.1158/1538-7445.AM2020-4295 [Poster]
Web of Science FullText FullText_MUG

Moser, T; Waldispuehl-Geigl, J; Belic, J; Weber, S; Zhou, Q; Hasenleithner, S; Graf, R; Terzic, JA; Posch, F; Sill, H; Lax, S; Kashofer, K; Hoefler, G; Schoellnast, H; Bauernhofer, T; Heitzer, E; Geigl, JB; Speicher, MR Real-time measurements of circulating tumor DNA levels during FOLFOX treatment in patients with colorectal cancer.
4th Annual Meeting of the ÖPPM; Vienna, AUSTRIA. 2020. [Poster]

Perakis, SO; Weber, S; Graf, R; Zhou, Q; Riedl, JM; Dandachi, N; Balic, M; Gerger, A; Schuuring, E; Groen, HJ; Geigl, JB; Speicher, MR; Heitzer, E Identification of actionable targets in advanced cancer patients from circulating tumor DNA using clinical decision support platforms
CANCER RES. 2020; 80(16):-AACR Annual Meeting; JUN 22-24, 2020; ELECTR NETWORK. Doi: 10.1158/1538-7445.AM2020-1315 [Poster]
Web of Science FullText FullText_MUG

Perakis, SO; Weber, S; Zhou, Q; Graf, R; Hojas, S; Riedl, JM; Gerger, A; Dandachi, N; Balic, M; Hoefler, G; Schuuring, E; Groen, HJM; Geigl, JB; Heitzer, E; Speicher, MR Liquid biopsy profiling of advanced cancer patients for clinical decision support platform analysis.
ÖGPath Frühjahrstagung 2020; SEP 11-12, 2020; Vienna, AUSTRIA. 2020. [Oral Communication]

Lampignano, R; Neumann, MHD; Weber, S; Kloten; V, Herdean; A; Voss, T; Groelz, D; Babayan, A; Tibbesma, M; Schlumpberger, M; Chemi, F;. Rothwell, DG; Wikman, H; Galizzi, JP; Bergheim, IR, Russnes, H; Mussolin, B; Bonin, S; Voigt, C; Musa, H; Pinzani, P; Lianidou, E; Brady, G; Speicher, MR; Pantel, K; Betsou, F; Schuuring, E; Kubista, M; Ammerlaan, W; Sprenger-Haussels, M; Schlange; T; Heitzer, E. Multicenter evaluation of ccfDNA extraction and downstream analyses for the development of standardized (pre)analytical workflows
Advances in Circulating Tumor Cells (ACTC) 2019; SEP 2-6, 2019; Corfu, GREECE. 2019. [Oral Communication]
FullText

Brudzewsky, D; Lampignano, R; Weber, S; Sartori, A; Mohan, S; Konigshofer, Y; Davis, L; Rothwell, D; Schuuring, E; Garlick, RK; Schlange, T; Heitzer, E Multicenter evaluation of circulating tumor DNA assays
CANCER RES. 2019; 79(13): Doi: 10.1158/1538-7445.AM2019-438 [Poster]
Web of Science FullText FullText_MUG

Heitzer, E on behalf of Cancer-ID Multicenter evaluation of ccfDNA extraction and downstream analyses for the development of standardized (pre)analytical workflows
ESHG 2019 https://2019.eshg.org/; JUN, 12-16; Gotenborg, SWEDEN. 2019. [Oral Communication]
FullText

Jungst, C; Stadlbauer, V; Reichert, M; Weber, S; Ofner-Ziegenfuss, L; Voigtlander, T; Spindelbock, W; Fickert, P; Kirchner, G; Lammert, F; Lankisch, TO; Krawczyk, M NOD2 variants as novel genetic risk factors for secondary sclerosing cholangitis in critically ill patients
J HEPATOL. 2017; 66(1):S358-S358.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS. [Poster]
Web of Science

Perakis S, Zhuo Q, Weber S, Ulz P, Geigl JB, Speicher MR and Heitzer E Diagnostic workflows for liquid biopsy approaches
http://journals.sagepub.com/doi/full/10.1177/1010428317742551. 2017; -ISOBM 2017 ; SEP 4-7, 2017; Rio de Janerio, BRASIL. [Oral Communication]
FullText

↑ Top of page / Navigation